Cyclacel Pharmaceuticals
NASDAQ: CYCC
Healthcare
Biotechnology
Rank
#33620
Market Cap
25.92 M
Volume
144,455
Price
2
Change (%)
9.09%
Country or region
Malaysia
Malaysia
Cyclacel Pharmaceuticals Stock Split History Overview
This company has undergone a total of five stock splits throughout its history. Five reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on 05/12/2025 with a ratio of 1-for-16. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Cyclacel Pharmaceuticals (NASDAQ: CYCC) Stock Split History
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| 05/12/2025 | 1:16 | x0.0625 | x2.4801593E-06 | Reverse |
| 12/18/2023 | 1:15 | x0.06666667 | x3.968255E-05 | Reverse |
| 04/15/2020 | 1:20 | x0.05 | x0.0005952382 | Reverse |
| 05/31/2016 | 1:12 | x0.083333336 | x0.011904763 | Reverse |
| 08/27/2012 | 1:7 | x0.14285715 | x0.14285715 | Reverse |
Frequently Asked Questions
If Cyclacel Pharmaceuticals (stock symbol: NASDAQ: CYCC) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-16) that occurred on 05/12/2025.
Cyclacel Pharmaceuticals (stock symbol: NASDAQ: CYCC) has undergone a total of five stock splits. The most recent split occurred on 05/12/2025. One share bought prior to the first split on 08/27/2012 would now equal 0.00 shares.
Cyclacel Pharmaceuticals (stock symbol: NASDAQ: CYCC) has undergone five stock splits in its history. The most recent split, a 1-for-7 split, occurred on 05/12/2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.
